Ouro Medicines is a biotechnology company focused on developing immune reset therapeutics for people living with chronic immune-mediated diseases. Based in the San Francisco Bay Area, it highlights a scientific focus on immunology-driven approaches and clinical development programs. The company communicates a roadmap that includes clinical trials and expanded access policies as part of its pipeline strategy. Ouro Medicines operates internationally with a research-centric stance toward treating immune-mediated conditions.
No recent news for this company.